Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling

Journal of Molecular and Cellular Cardiology

Volumn 67, Issue , 2014, Pages 38-48

  Wright, Peter T ^a   Nikolaev, Viacheslav O ^a,b   O'Hara, Thomas ^e   Diakonov, Ivan ^a   Bhargava, Anamika ^a   Tokar, Sergiy ^a   Schobesberger, Sophie ^a   Shevchuk, Andrew I ^c   Sikkel, Markus B ^a   Wilkinson, Ross ^a   Trayanova, Natalia A ^e   Lyon, Alexander R ^a,d   Harding, Sian E ^a   Gorelik, Julia ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e Johns Hopkins University   (United States)

Author keywords

Beta adrenergic receptors; Cardiomyocytes; FRET; SICM; T tubules

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; CAVEOLIN 3; CYCLIC AMP; MUTANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE OVEREXPRESSION; HEART FAILURE; HEART MUSCLE CELL; INTRACELLULAR SIGNALING; MALE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; WILD TYPE;

ADULT RAT VENTRICULAR MYOCYTES; ARVM; BETA-ADRENERGIC RECEPTORS; CARDIOMYOCYTES; CAV3; CAV3DN; CAVEOLIN-3; CAVEOLIN-3 DOMINANT NEGATIVE MUTANT; FLUORESCENCE RESONANCE ENERGY TRANSFER; FRET; HEART FAILURE; HF; METHYL-Β-CYCLODEXTRIN; MΒCD; SCANNING ION CONDUCTANCE MICROSCOPY; SICM; T-TUBULES; Β-ADRENERGIC RECEPTOR; Β-AR;

ANIMALS; BLOTTING, WESTERN; CAVEOLIN 3; COMPARTMENT SYNDROMES; COMPUTER SIMULATION; CYCLIC AMP; GENE EXPRESSION; HEART FAILURE; MYOCYTES, CARDIAC; RATS; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 84892851624     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.12.003     Document Type: Article

References (48)

1. Brodde O.E., Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999, 51:651-690.
2. Xiang Y., Kobilka B.K. Myocyte adrenoceptor signaling pathways. Science 2003, 300:1530-1532.
3. Lohse M.J., Engelhardt S., Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?. Circ Res 2003, 93:896-906.
4. Schäfer M., Frischkopf K., Taimor G., Piper H.M., Schlüter K.-D. Hypertrophic effect of selective β1-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am J Physiol Cell Physiol 2000, 279:C495-C503.
5. Zhu W.-Z., Zheng M., Koch W.J., Lefkowitz R.J., Kobilka B.K., Xiao R.-P. Dual modulation of cell survival and cell death by β2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci 2001, 98:1607-1612.
6. Engelhardt S., Hein L., Wiesmann F., Lohse M.J. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 1999, 96:7059-7064.
7. Dorn G.W., Tepe N.M., Lorenz J.N., Koch W.J., Liggett S.B. Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice. Proc Natl Acad Sci U S A 1999, 96:6400-6405.
8. Xiao R.-P. {beta}-Adrenergic signaling in the heart: dual coupling of the {beta}2-adrenergic receptor to Gs and Gi proteins. Sci Signal 2001, 2001:re15.
9. Xiao R.P., Ji X., Lakatta E.G. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 1995, 47:322-329.
10. Nikolaev V.O., Bünemann M., Schmitteckert E., Lohse M.J., Engelhardt S. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching β1-adrenergic but locally confined β2-adrenergic receptor-mediated signaling. Circ Res 2006, 99:1084-1091.
11. Head B.P., Patel H.H., Roth D.M., Lai N.C., Niesman I.R., Farquhar M.G., et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 2005, 280:31036-31044.
12. Xiang Y., Rybin V.O., Steinberg S.F., Kobilka B. Caveolar localization dictates physiologic signaling of β2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem 2002, 277:34280-34286.
13. Agarwal S.R., MacDougall D.A., Tyser R., Pugh S.D., Calaghan S.C., Harvey R.D. Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes. J Mol Cell Cardiol 2011, 50:500-509.
14. Ostrom R.S., Violin J.D., Coleman S., Insel P.A. Selective enhancement of β-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 2000, 57:1075-1079.
15. Rybin V.O., Xu X., Lisanti M.P., Steinberg S.F. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. J Biol Chem 2000, 275:41447-41457.
16. Cohen A.W., Hnasko R., Schubert W., Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol Rev 2004, 84:1341-1379.
17. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol Rev 2002, 54:431-467.
18. Shaul P.W., Anderson R.G.W. Role of plasmalemmal caveolae in signal transduction. Am J Physiol Lung Cell Mol Physiol 1998, 275:L843-L851.
19. Harvey R.D., Calaghan S.C. Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology. J Mol Cell Cardiol 2012, 52:366-375.
20. Gratton J.P., Bernatchez P., Sessa W.C. Caveolae and caveolins in the cardiovascular system. Circ Res 2004, 94:1408-1417.
21. Lisanti M.P., Scherer P.E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., Tu Y.H., et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994, 126:111-126.
22. Feron O., Balligand J.L. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 2006, 69:788-797.
23. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002, 416:337-339.
24. Parton R.G., Way M., Zorzi N., Stang E. Caveolin-3 associates with developing t-tubules during muscle differentiation. J Cell Biol 1997, 136:137-154.
25. Galbiati F., Volonte D., Chu J.B., Li M., Fine S.W., Fu M., et al. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci U S A 2000, 97:9689-9694.
26. Repetto S., Bado M., Broda P., Lucania G., Masetti E., Sotgia F., et al. Increased number of caveolae and caveolin-3 overexpression in duchenne muscular dystrophy. Biochem Biophys Res Commun 1999, 261:547-550.
27. Woodman S.E., Park D.S., Cohen A.W., Cheung M.W.C., Chandra M., Shirani J., et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002, 277:38988-38997.
28. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M., et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem 2001, 276:21425-21433.
29. Calaghan S., White E. Caveolae modulate excitation-contraction coupling and β2-adrenergic signalling in adult rat ventricular myocytes. Cardiovasc Res 2006, 69:816-824.
30. Balijepalli R.C., Foell J.D., Hall D.D., Hell J.W., Kamp T.J. Localization of cardiac L-type Ca2+ channels to a caveolar macromolecular signaling complex is required for β2-adrenergic regulation. Proc Natl Acad Sci 2006, 103:7500-7505.
31. Chen-Izu Y., Xiao R.-P., Izu L.T., Cheng H., Kuschel M., Spurgeon H., et al. Gi-dependent localization of β2-adrenergic receptor signaling to L-type Ca2+ channels. Biophys J 2000, 79:2547-2556.
32. Wagner E., Lauterbach M.A., Kohl T., Westphal V., Williams G.S., Steinbrecher J.H., et al. Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction. Circ Res 2012, 111:402-414.
33. Lyon A.R., MacLeod K.T., Zhang Y., Garcia E., Kanda G.K., Lab M.J., et al. Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proc Natl Acad Sci U S A 2009, 106:6854-6859.
34. Nikolaev V.O., Moshkov A., Lyon A.R., Miragoli M., Novak P., Paur H., et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010, 327:1653-1657.
35. Koga A., Oka N., Kikuchi T., Miyazaki H., Kato S., Imaizumi T. Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension 2003, 42:213-219.
36. Hannawacker A., Krasel C., Lohse M.J. Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the β2-adrenergic receptor. Mol Pharmacol 2002, 62:1431-1437.
37. Nikolaev V.O., Gambaryan S., Engelhardt S., Walter U., Lohse M.J. Real-time monitoring of the PDE2 activity of live cells. J Biol Chem 2005, 280:1716-1719.
38. Heijman J., Volders P.G., Westra R.L., Rudy Y. Local control of beta-adrenergic stimulation: effects on ventricular myocyte electrophysiology and Ca(2+)-transient. J Mol Cell Cardiol 2011, 50:863-871.
39. Galbiati F., Volonté D., Minetti C., Chu J.B., Lisanti M.P. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). J Biol Chem 1999, 274:25632-25641.
40. Wong J., Baddeley D., Bushong E.A., Yu Z., Ellisman M.H., Hoshijima M., et al. Nanoscale distribution of ryanodine receptors and caveolin-3 in mouse ventricular myocytes: dilation of T-tubules near junctions. Biophys J 2013, 104:L22-L24.
41. Macdougall D.A., Agarwal S.R., Stopford E.A., Chu H., Collins J.A., Longster A.L., et al. Caveolae compartmentalise beta2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte. J Mol Cell Cardiol 2012, 52:388-400.
42. Communal C., Singh K., Sawyer D.B., Colucci W.S. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 1999, 100:2210-2212.
43. Tsutsumi Y.M., Horikawa Y.T., Jennings M.M., Kidd M.W., Niesman I.R., Yokoyama U., et al. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation 2008, 118:1979-1988.
44. Ratajczak P., Damy T., Heymes C., Oliviero P., Marotte F., Robidel E., et al. Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. Cardiovasc Res 2003, 57:358-369.
45. Oka N., Asai K., Kudej R.K., Edwards J.G., Toya Y., Schwencke C., et al. Downregulation of caveolin by chronic beta-adrenergic receptor stimulation in mice. Am J Physiol 1997, 273:C1957-C1962.
46. Piech A., Massart P.E., Dessy C., Feron O., Havaux X., Morel N., et al. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2002, 282:H219-H231.
47. Fujita T., Toya Y., Iwatsubo K., Onda T., Kimura K., Umemura S., et al. Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc Res 2001, 51:709-716.
48. Knowles C.J., Cebova M., Pinz I.M. Palmitate diet-induced loss of cardiac caveolin-3: a novel mechanism for lipid-induced contractile dysfunction. PLoS One 2013, 8:e61369.